- Home
- ACXP vs LGL Comparison
ACXP vs LGL Comparison
Compare ACXP & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- LGL
- Stock Information
- Founded
- ACXP 2017
- LGL 1917
- Country
- ACXP United States
- LGL United States
- Employees
- ACXP N/A
- LGL N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- LGL Industrial Machinery/Components
- Sector
- ACXP Health Care
- LGL Technology
- Exchange
- ACXP Nasdaq
- LGL Nasdaq
- Market Cap
- ACXP 31.4M
- LGL 31.5M
- IPO Year
- ACXP 2021
- LGL N/A
- Fundamental
- Price
- ACXP $0.76
- LGL $6.89
- Analyst Decision
- ACXP Strong Buy
- LGL
- Analyst Count
- ACXP 1
- LGL 0
- Target Price
- ACXP $12.00
- LGL N/A
- AVG Volume (30 Days)
- ACXP 159.4K
- LGL 4.2K
- Earning Date
- ACXP 03-14-2025
- LGL 03-31-2025
- Dividend Yield
- ACXP N/A
- LGL N/A
- EPS Growth
- ACXP N/A
- LGL 66.76
- EPS
- ACXP N/A
- LGL 0.07
- Revenue
- ACXP N/A
- LGL $4,130,000.00
- Revenue This Year
- ACXP N/A
- LGL N/A
- Revenue Next Year
- ACXP N/A
- LGL N/A
- P/E Ratio
- ACXP N/A
- LGL $95.59
- Revenue Growth
- ACXP N/A
- LGL 26.49
- 52 Week Low
- ACXP $0.68
- LGL $4.86
- 52 Week High
- ACXP $3.35
- LGL $7.00
- Technical
- Relative Strength Index (RSI)
- ACXP 44.44
- LGL 56.39
- Support Level
- ACXP $0.73
- LGL $6.50
- Resistance Level
- ACXP $0.82
- LGL $7.00
- Average True Range (ATR)
- ACXP 0.05
- LGL 0.26
- MACD
- ACXP 0.01
- LGL -0.03
- Stochastic Oscillator
- ACXP 31.87
- LGL 85.33
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.